TGFB1 and non-small cell lung carcinoma: When this small molecular inhibitor was linked to αvβ6 receptor, it reduced TGFβ‐induced EMT in human NSCLC cells, highlighting the role of αvβ6 receptors as an efficacious targeting approach against NSCLC [252].